Home / Knowledge Centre /

Have you got the physical form of your API under control?

Selection and isolation of the correct stable polymorph is a key driver for confidence in your API product, with crystallization as the key to success. Starting from historical considerations and moving through to modern techniques for creating the required final dosage form, Dr Jonathan Loughrey and Professor Tom Moody of Almac Group describe strategies to ensure that a robust process for a crystalline product is achieved.

View Resource
Almac Logo

Almac API, Chemical Development, Analytical & Solid State Services

Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).

We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.

Learn More

We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.

Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies